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Summary
QUESTIONS UNDER STUDY: Completeness is import-
ant in cancer registration. Identifying areas to improve re-
gistry procedures might help to maximise completeness.
We examined characteristics of childhood cancer cases that
were registered via death certificate notification (DCN)
rather than during life, and estimated completeness of the
Swiss Childhood Cancer Registry (SCCR).
METHODS: We analysed data from all children who died
from cancer in Switzerland between 1985–2009 at age <16
years (n = 978), and checked whether they had been re-
gistered in the SCCR. We used multivariable logistic re-
gression to compare characteristics of DCN cases with
deceased SCCR cases, and the DCN-to-incidence and
mortality-to-incidence ratio method to estimate complete-
ness for different diagnostic periods.
RESULTS: Among 978 deceased children with cancer, 126
(12.9%) were registered via DCN. Those with tumours of
digestive organs (odds ratio [OR] 5.1; 95% confidence in-
terval [CI] 1.9–13.7), tumours of endocrine glands (OR
4.5; 95% CI 1.6–12.3), and brain tumours (OR 3.1; 95%
CI 1.7–5.5) were more likely to be DCN cases than those
with leukaemia. Neonates (OR 14.1, 95% CI 5.3–37.3), in-
fants (OR 7.5; 95% CI 3.1–18.0) and 14–15 year olds (OR
2.4; 95% CI 1.2–4.9) were more likely to be DCN cases
than 1–4 year olds. The DCN proportion was particularly
high in infants who lived in rural regions. Estimated com-
pleteness of the SCCR increased from 85% for 1985–89 to
≥95% for 1995–2009.
CONCLUSIONS: Childhood cancer registration in
Switzerland was quite complete, but registration must im-
prove for infants, particularly neonates, and children dia-
gnosed with hepatic, endocrine and brain tumours.
Key words: paediatrics; childhood cancer; registry;
completeness
Introduction
Population-based cancer registration monitors the cancer
burden in a region and creates a database for epidemi-
ological research [1, 2]. All incident cases should be re-
gistered to complete the data set [3]. Inconsistent registra-
tion of subgroups (e.g., a tendency to miss certain cancers,
or undercount age groups) can bias estimates [4]. Can-
cer registries can use death certificates to gather informa-
tion on unregistered cancer patients. The completeness of
a population-based cancer registry can be estimated on the
basis of the proportion of cases registered posthumously,
via a death certificate [4–7]. Registration procedures can be
improved by comparing patients identified through death
certificates with cases registered during life.
In its first three decades, the Swiss Childhood Cancer Re-
gistry (SCCR) was primarily notified of incident cases by
paediatric cancer centres. A previous study compared the
SCCR’s completeness with regional cancer registries for
1985–2004 and found that 22% of childhood cancer pa-
tients in regional registries had not been registered in the
SCCR [8]. These missed cases were registered retrospect-
ively for the whole study period, and the SCCR revised its
registration procedures. The SCCR now relies on a vari-
ety of notification sources (paediatric cancer centres, other
hospitals, pathology laboratories, regional cancer regis-
tries).
This study determined the completeness of the SCCR’s up-
dated registration process by investigating the number of
children who first came to its attention via death certific-
ate notification (DCN) [9–11]. We aimed to: (1) describe
the number of childhood cancer cases identified via DCN;
(2) describe patient groups that were more likely not to
be registered during life; and (3) estimate completeness of
the SCCR for different periods based on the proportion of
DCN cases.
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Materials and methods
The Swiss Childhood Cancer Registry
The SCCR was founded in 1976 by the Swiss Paediatric
Oncology Group, the association of the nine specialised
paediatric cancer centres (PCCs). The SCCR registers ma-
lignant solid tumours, leukaemias and lymphomas, central
nervous system (CNS) tumours (both malignant and be-
nign), and Langerhans cell histiocytosis diagnosed in chil-
dren <21 years in Switzerland [9, 11]. Children diagnosed
with cancer before they reach 15, and older adolescents
diagnosed with typical paediatric tumours, are usually
treated in one of the PCCs. A data manager in each PCC
actively notifies the SCCR of new cases, usually within
a month of diagnosis. In previous decades, some children
were treated outside PCCs, for example for leukaemia, in
smaller paediatric hospitals or adult haematology depart-
ments, or, for CNS tumours, in neurosurgery departments
[8]. In 2007, the SCCR started validating and improving
completeness of registration by comparing retrospectively
the dataset of the SCCR with datasets of regional (canton-
al) cancer registries [12].
Each diagnosis registered in the SCCR is classified accord-
ing to the 10th revision of the International Classification
of Diseases (ICD), topography and morphology of the third
revision of the ICD for Oncology (ICD-O-3), and accord-
ing to the third edition of the International Classification
of Childhood Cancer (ICCC-3) [13–15]. The SCCR up-
dates vital status and date of death based on routine quer-
ies to municipal registries in Switzerland. The SCCR also
receives information on cancer mortality from the Swiss
Federal Statistical Office (SFSO), including all death certi-
ficates that list neoplasm as cause of death for Swiss resid-
ents [10, 16].
Study design
We determined if all children whose death certificates men-
tioned cancer were registered in the SCCR at time of dia-
gnosis. We included all records that listed one or more
causes of death as cancer: underlying cause of death; in-
termediate and immediate cause of death; and up to two
causes not directly linked to the train of morbid events.
Until December 31 1994 the SFSO coded according to
ICD-8 (3-digit codes 140-209, 225 and 238); from January
1 1995 on according to ICD-10 (codes C00-C97, D33 and
D43; table 1). We classified types of cancer according
to sub-blocks of the ICD-8 and ICD-10 systems (table
1). The categories “Tumours of digestive organs”, “Tu-
mours of bone, cartilage and connective tissue” and “Tu-
mours of endocrine glands” overlapped in the 3-digit sys-
tem of ICD-8 and ICD-10 so we used these. Tumours of the
nervous system do not overlap in the ICD-8 and ICD-10
sub-blocks, so we adapted the grouping slightly, differen-
tiating between “Brain tumours” and “Tumours of other
parts of the nervous system”. We also included neoplasms
of benign or uncertain behaviour of the brain (ICD-8, 225;
ICD-10, D33.0 – D33.2 and D43.0-D43.2), since they are
used in the ICCC-3 and are usually included in childhood
cancer registries. We divided the sub-block that includes
neoplasms of lymphatic and haematopoietic tissue into
“Lymphoma” (ICD-8, 200-203; ICD-10, C81-C86) and
“Leukaemia” (ICD-8, 204-207; ICD-10, C91-C96).
We included records from children resident in Switzerland
who died before age 16 years between January 1 1985, and
December 31 2009. We defined a case as a DCN if cancer
was mentioned on the death certificate, but the child had
not been registered in the SCCR [4].
We extracted the dataset from the SCCR on December 31
2013, which gave us an interval of at least 4 years between
diagnosis and notification from sources other than death
certificates. Since death certificates in Switzerland are an-
onymous, we first used probabilistic linkage to link re-
cords from death certificates to deceased persons from the
SCCR. We used variables present in both datasets (sex,
date of birth, date of death and municipal number at date of
death). Next, we double-checked linkage results manually
and verified unclear cases.
Data analysis
We used STATA version 13.1 for statistical analyses
(StataCorp. 2005. Stata Statistical Software: Release 13.1
StataCorp LP, College Station, TX, USA). We categorised
type of cancer into eight subgroups (table 1). We categor-
ised age at death into neonatal period (<28 days), infancy
(age 28–365 days), and 1–4, 5–9, 10–13 and 14–15 years.
For comparison, we used the same age categories as pre-
vious studies in Switzerland [8]. We used a classification
of the SFSO to distinguish “urban” (main urban centres
or urban agglomeration around centres) and “rural” (towns
without surrounding agglomeration and rural communities)
municipalities [17]. We classified three official language
regions: German, French, and Italian/Romansh. For each
child, we categorised a binary variable to signal if the com-
munity they lived in was covered by a regional cancer re-
gistry at time of diagnosis.
Table 1: Classification of types of cancer based on ICD-8 and ICD-10.
Type of cancer (ICD-8/10 main groups) ICD-8a ICD-10b
Tumours of digestive organs 150–159 C15–C26
Tumours of bone, cartilage and connective tissue 170–171 C40–C41, C45–C46, C48–C49
Brain tumours (benign and malignant) 191, 225 C71, D33.0–D33.2, D43.0–D43.2
Tumours of other parts of nervous system 192 C47, C72
Tumours of endocrine glands 194 C73-C75
Lymphoma 200–203 C81-C86
Leukaemia 204–207 C91-C95
Other tumours 140–207 excluding the above mentioned C00–C96 (excluding the above
mentioned)
a International Classification of Diseases 8th revision
b International Classification of Diseases 10th revision
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First, we computed the proportion of DCN cases with 95%
confidence intervals (CIs) among all deceased cases in the
SCCR, and then in subgroups defined by period of diagnos-
is and patient characteristics.
Second, we determined characteristics associated with
DCN registration, comparing DCN cases with deceased
SCCR cases. Associations are presented as odds ratios
(ORs) with 95% CI, where an OR of less than one indicates
decreased likelihood that a person was registered in their
lifetime. Our multivariable model included all variables
significant at the p <0.05 level in the univariable regres-
sion, plus sex. We tested all exposure variables for inter-
action with period of death. Since we found no significant
interactions these were not included in the final multivari-
able model. Reference categories for logistic regression
analysis were those with the largest number of individu-
als: sex (male); type of cancer (leukaemia); age at death
(1–4 years); municipality (urban); language region (Ger-
man); and, coverage by regional cancer registration (yes),
or as the first category for year of death (1985–1989). In
a post-hoc analysis, we continued to explore data from in-
fants, because of their high risk of DCN notification. Since
the absolute number of infants was small, we categorised
cancers into broader groups. We used Fisher’s exact test
and likelihood ratio tests to test statistical significance, and
added interaction terms to the regression models to assess
effect modification. All p-values were two-sided; a p-value
of < 0.05 indicated statistical significance.
Third, we used the formula proposed by Parkin et al. to es-
timate completeness of the SCCR based on the proportion
of DCN cases [5]. An estimate of completeness (CSCCR) is
given by
DCN:I represents the DCN to incidence ratio, defined as
the number of DCN cases divided by the total number
of diagnosed cancer cases (including the number of DCN
cases) in a specific period. We defined mortality to in-
cidence ratio (M:I) as the number of deaths divided by
the number of new cases diagnosed in that period. We
defined incident cases as all cancers (ICCC-3 main groups
I-XII) diagnosed in Swiss resident children up to 16 years
between 1985–2009. As required by the method, the num-
ber of incident and mortality cases included DCN cases to
estimate completeness. For DCN cases, we approximated
the date of diagnosis by the date of death.
Results
Proportion of DCN cases among all children who died
from cancer
From January 1985 to December 2009, cancer was men-
tioned on the death certificate of 978 children. None men-
tioned more than one cause of death related to cancer. Of
these 978 children, 852 (87%) were registered in the SCCR
during lifetime and 126 (13%) were registered as DCN
cases (table 2). This proportion declined over time, from
26% in 1985–1989, to 5% in 2005-2009 (table 2). Among
deceased SCCR patients, the mean age at diagnosis was 6.0
years (4.4; range 0.0–15.9), and the mean time from dia-
gnosis to death was 2.02 years (2.2; range 0.0–14.7). None
of the exposure variables contained missing values.
Characteristics of childhood cancer patients notified
via death certificates
The proportion of DCN among deceased childhood cancer
patients differed significantly (p <0.05) between type of
cancer, age at death, language region, and coverage by re-
gional cancer registration (table 2). DCN detected 27% per-
cent of children with tumours of digestive organs, but only
8% of those with leukaemia. DCN proportion was highest
in children who died during the neonatal period (<28 days,
50%) or during infancy (28 days–365 days, 30%) and low-
est (9%) among those who died aged 1–4 years. DCN pro-
portion ranged regionally from 20% to 14% and 6% in
Italian, German and French speaking areas, respectively;
and from 17% in regions without cancer registries to 7% in
regions covered by a regional cancer registry. DCN propor-
tion tended to be higher in rural municipalities (15%) than
in urban municipalities (12%), but was not statistically sig-
nificant (p = 0.185). We found no difference by sex (p =
0.485).
In the multivariable logistic regression, DCN remained
more common among children with tumours of digestive
organs (OR 5.1, 95% CI 1.9–13.7), tumours of endocrine
glands (OR 4.5, 95% CI 1.6–12.3), and brain tumours (OR
3.1, 95% CI 1.7–5.5) than among those with leukaemia. We
detected more DCN cases in neonates (death at <28 days,
OR 14.1, 95% CI 5.3–37.3) and infants beyond the neonat-
al period (death at day 28–365, OR 7.5, 95% CI 3.1–18.0),
and in teenagers (death at age 14–15 years, OR 2.4, 95%
CI 1.2–4.9) than in children who died at age 1–4 years.
DCN cases were less frequent among those who lived in
regions covered by regional cancer registries (OR 0.4, 95%
CI 0.2–0.6). In the multivariable model, language region
was no longer significantly associated with DCN. We did
not find any evidence for an interaction between year of
death and the other exposure variables.
Subgroup analysis for infants
Among 74 infants who died of cancer in their first year of
life, 28 (38%) were notified via death certificate (table 3).
In contrast to the findings for older children, in infants, the
DCN proportion did not decrease over time, but remained
high (31%) even in the most recent period. The proportion
of DCN cases was high for both girls and boys, and for all
types of cancer. It was higher for infants who lived in rural
municipalities (68%) than for those who lived in urban mu-
nicipalities (27%). It was also higher for children who lived
in a region without a regional cancer registry (51%) than in
a region covered by regional cancer registration (21%). The
causes of death of all 28 infants identified by death certific-
ate were verified by autopsy. In 12 cases, the death certific-
ate noted the place it was issued; six (50%) were issued by
neonatal wards, three (25%) by a private practitioner, two
(17%) by intensive care units, and only one (12%) by a pae-
diatric oncology ward.
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Estimate of completeness of the SCCR
A total of 4 435 children were diagnosed with cancer dur-
ing the study (including DCN cases); 978 died from cancer.
The DCN:I ratio was 0.03; the M:I ratio was 0.22 (table 4).
We used the formula proposed by Parkin et al. to estimate
91% completeness over the whole study period [5]. Com-
pleteness increased significantly over study time, from
85% in 1985–1989, to 90% in 1990–1994, 95% in
1995–1999, 95% in 2000–2004 and 96% in 2005–2009
(table 4). This increase is explained by the decreasing num-
ber of DCN cases, and counteracted partly by the decreas-
ing M:I ratio, which fell from 0.318 in 1985–1989 to 0.167
in 2005–2009 (table 4). The M:I ratio decrease between the
first to the second time period was mainly influenced by
an increase in incident cases (694 vs 902). In later peri-
ods, incidence was more stable and the M:I ratio was influ-
enced mostly by the decreasing number of deaths (239 in
1990–1994 to 155 in 2005–2009).
Discussion
Main findings
This first study on DCN registration in the SCCR found
that DCN proportions varied widely between patient
groups. It provided the first estimates of completeness of
childhood cancer registration in Switzerland. Age was the
best predictor of DCN registration: infants who died from
cancer (in particular, neonates) were most likely not to have
been registered while alive, as were teenagers who died at
14–15 years. Children with rare tumours such as tumours
of digestive organs and tumours of endocrine glands, and
children with brain tumours were also very likely to miss
Table 2: Characteristics of childhood cancer cases notified via death certificate .
Deceased
children
with cancera
DCN cases Univariable analysis Multivariable analysisd
Variable n n % (95% CI) OR (95% CI)b p-valuec OR (95% CI)b p-valuec
All patients 978 126 12.9 (10.9–15.1)
Gender 0.485 0.606
Male 556 68 12.2 (9.8–15.2) 1 1
Female 422 58 13.7 (10.8–17.4) 1.1 (0.8–1.7) 1.1 (0.7–1.7)
Type of cancer mentioned on death certificate 0.006 <0.001
Tumours of digestive organs 34 9 26.5 (14.2–43.8) 4.1 (1.8–9.8) 5.1 (1.9–13.7)
Tumours of bone, cartilage and connective tissue 97 8 8.2 (4.2–15.7) 1.0 (0.5–2.4) 0.7 (0.3–1.8)
Brain tumours (benign and malignant) 261 39 14.9 (11.1–19.9) 2.0 (1.2–3.4) 3.1 (1.7–5.5)
Tumours of other parts of nervous system 63 13 20.6 (12.3–32.5) 3.0 (1.4–6.2) 1.5 (0.6–3.3)
Tumours of endocrine glands 54 7 13.0 (6.3–24.9) 1.7 (0.7–4.2) 4.5 (1.6–12.3)
Lymphoma 45 7 15.6 (7.5–29.4) 2.1 (0.9–5.2) 1.7 (0.6–4.4)
Leukaemia 325 26 8.0 (5.5–11.5) 1 1
Other tumours 99 17 17.2 (10.9–26.0) 2.4 (1.2–4.6) 2.4 (1.1–5.0)
Age at death <0.001 <0.001
<28 days 30 15 50.0 (32.5–67.5) 10.1 (4.4–23.5) 14.1 (5.3–37.3)
28 days–365 days 44 13 29.6 (17.9–44.7) 4.3 (1.9–9.3) 7.5 (3.1–18.0)
1–4 years 245 24 9 (6.0–13.3) 1 1
5–9 years 301 29 9.6 (6.0–13.5) 1.1 (0.6–1.9) 1.2 (0.6–2.2)
10–13 years 215 23 10.7 (7.2–15.6) 1.2 (0.7–2.2) 1.5 (0.8–2.9)
14–15 years 143 24 16.8 (11.5–23.9) 2 (1.1–3.8) 2.4 (1.2–4.9)
Year of death <0.001 <0.001
1985–1989 221 58 26.2 (20.8–32.5) 1 1
1990–1994 239 36 15.1 (11.1–20.2) 0.5 (0.3–0.8) 0.5 (0.3–0.8)
1995–1999 168 12 7.1 (4.1–12.2) 0.2 (0.1–0.4) 0.1 (0.1–0.3)
2000–2004 195 12 6.2 (3.5–10.5) 0.2 (0.1–0.4) 0.2 (0.1–0.3)
2005–2009 155 8 5.2 (2.6–10.0) 0.2 (0.1–0.3) 0.1 (0.0–0.2)
Municipality 0.185 –
Urban 679 81 11.9 (9.7–14.6) 1
Rural 299 45 15.1 (11.4–19.6) 1.3 (0.9–1.9)
Language region 0.001 0.121
German 714 103 14.4 (12.0–17.2) 1 1
French 215 13 6.1 (3.5–10.2) 0.4 (0.2–0.7) 0.5 (0.3–1.0)
Italian/Romansh 49 10 20.4 (11.3–34.1) 1.5 (0.7–3.1) 1.1 (0.5–2.4)
Regional cancer registration <0.001 <0.001
Yes 371 25 6.7 (4.6–9.8) 0.4 (0.2–0.6) 0.4 (0.2–0.6)
No 607 101 16.6 (13.9–19.8) 1 1
CI = confidence interval; DCN = death certificate notification; OR = odds ratio; SCCR = Swiss Childhood Cancer Registry
a This includes all deceased children registered in the SCCR and DCN cases
b From logistic regression models
c From likelihood ratio test
d Multivariable analyses are adjusted for all variables shown
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registration in the SCCR. Infants who lived in more remote
regions were more often registered via DCN. The propor-
tion of DCN cases was lower in regions covered by re-
gional cancer registries (7% compared to 17%), but not
0%. Completeness of the SCCR improved during the study
period. It has been about 95% since 1995.
Main findings in the context of other findings
Likelihood of DCN registration varied most between age
groups and between tumour types. We found only one in-
ternational study that investigated patient characteristics
associated with death certificate only (DCO) cases in
southeast England from 1987–1989 [18]. It included cancer
cases of all age groups; place of residence, age, sex, sur-
vival time and place of death (e.g. oncology ward, general
hospital or home) were independent predictors of DCOs
among deceased patients. In that study, the likelihood of
DCO registration varied most between places of death:
those who died in an extraregional hospital were more of-
ten DCO registered than those who died in a National
Health Service (NHS) acute hospital. Unfortunately, we
had no information on place of death, but the SCCR em-
ploys data managers in all nine PCCs in Switzerland, so
we assume that most DCN cases died outside paediatric
oncology centres and thus were not registered. Children
with brain tumours, for example, may have been treated
in neurology or neurosurgery wards. Infants were likely to
have been treated in neonatal wards or paediatric intensive
care units, with no paediatric oncologist involved, which
might also explain the high proportion of DCN among in-
Table 3: Characteristics of infant cancer cases identified via death certificate notification.
Deceased
infants with
cancera
DCN cases
Variable n n % (95% CI) p-valueb
All patients 74 28 37.8 (27.3–49.6)
Sex 0.343
Male 34 15 44.1 (28.2–61.4)
Female 40 13 32.5 (19.6–48.8)
Type of cancer mentioned on death certificate 0.122
Tumours of digestive organs and endocrine glands 10 5 50.0 (20.9–79.1)
Tumours of bone, cartilage and connective tissue 11 4 36.4 (13.4–67.9)
Brain tumours (benign and malign) and tumours of other parts of nervous system 25 7 28.0 (13.6–49.0)
Lymphoma/Leukaemia 14 3 21.4 (6.6–51.2)
Other tumours 14 9 64.3 (36.2–85.1)
Year of death 0.449
1985–1989 17 9 52.9 (29.3–75.3)
1990–1994 19 5 26.3 (10.9–50.9)
1995–1999 12 4 33.3 (12.3–64.1)
2000–2004 13 6 46.2 (21.3–73.1)
2005–2009 13 4 30.8 (11.3–60.7)
Language region 0.355
German 55 20 36.4 (24.5–50.1)
French 13 4 30.8 (11.3–60.7)
Italian/Romansh 6 4 66.7 (23.2–93.0)
Linkage with cantonal registry 0.009
Yes 33 7 21.2 (10.2–38.9)
No 41 21 51.2 (35.8–66.4)
Municipality 0.002
Urban 55 15 27.2 (16.9–40.8)
Rural 19 13 68.4 (44.1–85.6)
CI = confidence interval; DCN = death certificate notification; SCCR = Swiss Childhood Cancer Registry
a Deceased patients registered in the SCCR and DCN cases
b From Fisher’s exact test
Table 4: Completeness of the Swiss Childhood Cancer Registry during different time periods, calculated using the DC-M:I method.
Year Children with cancera Children deceased
due to cancerb
DCN cases DCN:Incidence ratioc M:Ie Completeness (%)
1985–2009 4 435 978 126 0.0284 0.2205 90.9
1985–1989 694 221 58 0.0836 0.3184 84.8
1990–1994 902 239 36 0.0399 0.265 90
1995–1999 898 168 12 0.0134 0.1871 94.5
2000–2004 1 005 195 12 0.0119 0.194 95.3
2005–2009 936 155 8 0.0085 0.1656 95.9
DCN = death certificate notification; M:I = mortality to incidence ratio; SCCR = Swiss Childhood Cancer Registry
a Childhood cancer cases registered in the SCCR and DCN cases
b Deceased cases registered in the SCCR and DCN cases
c Number of DCN cases divided by the number of all childhood cancer cases
Original article Swiss Med Wkly. 2015;145:w14225
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 5 of 7
fants in rural regions. Parents might first visit a local prac-
titioner or general oncologist before traveling to a distant
PCC. As we expected, regions covered by regional can-
cer registries had a lower proportion of DCN than regions
without registries (17% vs 74%). However, DCN cases
did not disappear completely in covered regions, suggest-
ing that some DCN cases are not registered in some re-
gional cancer registries. Several factors could have con-
tributed to the declining proportion of DCN for childhood
cancer over time. First, the organisational structure of the
SCCR changed, which might have helped reduce the pro-
portion of DCN. Important mile stones were: (1) introduc-
tion of financial rewards to the PCC for case notification
in 1990; (2) the change from paper files to an electronic
database in the mid-1990s; (3) incorporation of the SCCR
into the Institute of Social and Preventive Medicine at the
University of Bern in 2004, where case registration pro-
cedures were reorganised and the search for missing cases
and missing data intensified. Second, the number of region-
al cancer registries has grown since 1970, and SCCR data
exchange with these registries might have lowered the pro-
portion of DCN. Switzerland has no specialised clinics for
adolescents, so patients are cared for in many different in-
stitutions throughout the country. This makes registration
difficult, and we assume higher DCN proportions in ad-
olescents.
We estimated completeness of the national childhood can-
cer registry based on the proportion of DCN cases. We had
no direct comparison data for this. In the New Zealand
Cancer Registry (NZCR), Dockerty et al. estimated com-
pleteness for childhood cancer registration (age at diagnos-
is 0–14 years) using a three-source capture-recapture ap-
proach. Completeness was 99% during 1990–1993, assum-
ing independence of the sources [19]. In the UK, Kroll et al.
used a two-source capture-recapture approach to estimate
completeness for the National Registry of Childhood Tu-
mours (NRCT) (age at diagnosis 0–14 years) [20]. The au-
thors estimated a completeness of 99% during 2002–2003,
assuming sources were independent. General cancer regis-
tries, one of the sources in the British study, cover the
whole population in the UK, and this might explain why
they are more complete than Swiss registries, where, in
the past, only some regions were covered by regional can-
cer registries. In Brazil, two-source capture-recapture com-
pleteness estimates for childhood cancer in three cities
were 77%, 54% and 31% [21]. Brazil’s relatively low com-
pleteness estimates are consistent other emerging countries,
where it is difficult to register cancer patients. However,
directly comparing these results might be hard, since
capture-recapture and the DC and M:I method depend on
different assumptions and have different limitations.
Strengths and limitations
This study was strengthened by available mortality data
and additional information on individual patients. This al-
lowed us to analyse characteristics of DCN cases in detail.
Because we could access original death certificates, we val-
idated und updated coded causes of death. We used death
certificates to manually double-check results of the record,
changing record linkage from probabilistic to determinist-
ic. Overall mortality data in Switzerland are 97% complete
[22]. The SFSO reports that the missing 3% is mainly due
to Swiss citizens living abroad. This population is not rel-
evant for cancer registration.
The way we used death certificates could cause reporting
bias. Cancer may have been over-reported on death certi-
ficates, increasing DCN proportions, and causing underes-
timation of reported completeness. Cancer may also have
been under-reported on death certificates, decreasing DCN
proportions and causing us to overestimate completeness.
But we had access to all causes of death (underlying, con-
secutive and contributing) and we assume that virtually all
cancers detected and diagnosed by clinicians were men-
tioned on death certificates. Cancer diagnoses listed on
the death certificate may have been systematically mis-
classified, changing DCN proportions for specific child-
hood cancers. Coded causes of death also limit our study.
We coded causes of death with ICD-8 and ICD-10, which
define only a few histological types of cancer, and thus we
could not classify some tumour types diagnosed in chil-
dren, such as neuroblastoma and other peripheral nervous
cell tumours (ICCC-3 main group IV), soft tissue and other
extraosseous sarcomas (ICCC-3 main group IX) or germ
cell tumours, trophoblastic tumours, and gonadal neo-
plasms (ICCC-3 main group X) [13, 14]. We were also
limited by the small number of study subjects in some
analyses, which caused wide confidence intervals. Com-
pleteness estimates should also be interpreted with caution.
The DC and M:I method assumes that the probability of
death is the same in registered and unregistered cases [4].
If cancer survival between registered and unregistered chil-
dren is not the same, this assumption is violated. For ex-
ample, if fewer unregistered than registered cases survive,
the true total incidence would be overestimated and com-
pleteness underestimated. We do not know the true number
of unregistered cases who did not die. The DC and M:I
method also assumes that incidence and mortality ratios
were relatively constant throughout the period for which
we estimate completeness [4]. We needed to make this as-
sumption because our method is based on the M:I ratio.
Since M:I ratios changed over time (table 2), we divided
the study period into 5-year periods so the M:I ratios in
each period would be more stable.
Main message
Our results suggest high completeness of childhood cancer
registration in Switzerland. The SCCR will revise its re-
gistration procedures for infants, particularly neonates, and
children diagnosed with tumours of digestive organs, tu-
mours of endocrine glands and brain tumours to ensure that
most childhood cancer cases diagnosed in Switzerland will
be detected and included, and to maximise completeness.
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